Evidence map›Paper›PMID 20976247›Full record

ArticlePLoS genetics2010

A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions.

Dajiang J Liu, Suzanne M Leal

Abstract read
In one paragraph

Article in PLoS genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. iScience · 2025
    Article
  9. A Case-Control Study Supports Genetic Contribution of theAntioxidants (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dajiang J LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Suzanne M Leal

Funding

Northwest Genomics CenterRC2HL102926 · NHLBI · UNIVERSITY OF WASHINGTON · PI GREEN, PHILIP P, NICKERSON, DEBORAH A · 2009 to 2009
$11.0M
Identification of Nonsyndromic Hearing Impairment GenesR01DC003594 · NIDCD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SUZANNE M LEAL · 2004 to 2026
$7.7M
Genetic Susceptibility to Adverse Metabolic Consequences of ObesityRL1HL092550 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI COHEN, JONATHAN CHARLES · 2007 to 2011
$3.7M
Training in Pharmacoinformatics(RMI)R90DK071505 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI STANCEL, GEORGE M. · 2004 to 2008
$1.4M
NHLBI NIH HHS RC2 HL102926NHLBI NIH HHS RC2-HL102926NHLBI NIH HHS RL1 HL092550NHLBI NIH HHS RL1HL092550NIDCD NIH HHS R01 DC003594NIDCD NIH HHS R01-DC03594NIDDK NIH HHS 5 R90 DK071505-04NIDDK NIH HHS R90 DK071505
6 · The paper itself

Abstract

There is solid evidence that rare variants contribute to complex disease etiology. Next-generation sequencing technologies make it possible to uncover rare variants within candidate genes, exomes, and genomes. Working in a novel framework, the kernel-based adaptive cluster (KBAC) was developed to perform powerful gene/locus based rare variant association testing. The KBAC combines variant classification and association testing in a coherent framework. Covariates can also be incorporated in the analysis to control for potential confounders including age, sex, and population substructure. To evaluate the power of KBAC: 1) variant data was simulated using rigorous population genetic models for both Europeans and Africans, with parameters estimated from sequence data, and 2) phenotypes were generated using models motivated by complex diseases including breast cancer and Hirschsprung's disease. It is demonstrated that the KBAC has superior power compared to other rare variant analysis methods, such as the combined multivariate and collapsing and weight sum statistic. In the presence of variant misclassification and gene interaction, association testing using KBAC is particularly advantageous. The KBAC method was also applied to test for associations, using sequence data from the Dallas Heart Study, between energy metabolism traits and rare variants in ANGPTL 3,4,5 and 6 genes. A number of novel associations were identified, including the associations of high density lipoprotein and very low density lipoprotein with ANGPTL4. The KBAC method is implemented in a user-friendly R package.

Indexed as

Genetic VariationAlgorithmsAngiopoietin-Like Protein 3Angiopoietin-Like Protein 4Angiopoietin-Like Protein 6Angiopoietin-like ProteinsAngiopoietinsBlack or African AmericanComputational BiologyComputer SimulationEnergy MetabolismGenetic Predisposition to DiseaseHumansMonte Carlo MethodReproducibility of ResultsSequence Analysis, DNAAngiopoietin-Like Protein 3Angiopoietin-Like Protein 4Angiopoietin-Like Protein 6Angiopoietin-like ProteinsAngiopoietinsANGPTL3 protein, humanANGPTL4 protein, humanANGPTL5 protein, humanANGPTL6 protein, human

Identifiers

PMID20976247
PMCPMC2954824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.